Potentiation of infiltrating adaptive and innate immune cells and metabolic responses by environmental cadmium exposure following respiratory syncytial virus infection

Young-Mi Go,Ki-Hye Kim,Sang-Moo Kang
DOI: https://doi.org/10.4049/jimmunol.210.supp.236.17
2023-05-01
The Journal of Immunology
Abstract:Abstract Cadmium (Cd) accumulates in humans from regular dietary and environmental exposure including cigarette smoke, and occupational sources, and has a twenty-year biologic half-life. Most individuals have pre-existing immunity from early life exposure to respiratory syncytial virus (RSV) which causes serious lung disease and hospitalizations among the high-risk infants and elderly. Little is known about the effect of low environmental levels of Cd on inflammatory immune cell dynamics causing lung pathology in humans with RSV infection at early life. In this study, we examined the effects of low dose long-term Cd exposure after infant age RSV infection on phenotypes of infiltrating immune cells in a mouse model. C57BL/6J mice at 8 days old were exposed to RSV. A subset of RSV-infected mice was subsequently treated with Cd at a low dose in drinking water (3.0 mg CdCl 2/L) for 16 weeks. Flow cytometry and histology data showed that the levels of both T cells (CD4 +, CD4 +IFNg +, CD4 +IL4 +, CD4 +IL13 +) and innate immune cells (CD11b+, monocytes, neutrophil, eosinophil, dendritic cells, activated dendritic cells) appear to be linked to inflammatory lung pathology. In particular, the results showed that the levels of T cells and innate immune cells were substantially higher in the group of RSV infection followed by Cd treatment than the other groups (Cd or RSV alone), providing evidence that low dose Cd following early-life RSV infection enhanced lung inflammation. Consistently metabolic disruption was evident in the group of RSV infection followed by Cd treatment. Taken together, our study demonstrates that cumulative Cd burden following RSV infection has a significant impact on inflammatory immune cell infiltration, lung pathology, and metabolism. NIEHS Grants R01 ES031980 NIAID grans R01 AI54656 R21 AI147042
immunology
What problem does this paper attempt to address?